Foundayo vs. Oral Wegovy: Head-to-Head Oral GLP-1 Rivalry Heats Up
The ACHIEVE-3 trial in The Lancet showed Eli Lilly's Foundayo (orforglipron) superior on HbA1c, while Novo Nordisk's oral Wegovy may have an edge in weight-loss efficacy.
#oral-wegovy
3 stories
GoodRx to Match Novo Nordisk Price for Oral Semaglutide
GoodRx announced oral semaglutide availability via its telemedicine platform at $149 for lower doses, matching Novo Nordisk pricing and intensifying the GLP-1 price war.
Oral Wegovy Pill Expands Access to GLP-1 Therapy for Chronic Weight Management
The 25-mg oral semaglutide formulation broadens GLP-1 access for chronic weight management, with pharmacists playing a key role in patient counseling and adherence support.